Dolby Laboratories, Inc. (DLB) Income Statement
DLB FY2025 at a glance
Fiscal year ended September 30, 2025 · U.S. dollarsDLB revenue and net income
Where DLB's revenue goes
FY2025Each bar shows an amount and its share of revenue. DLB kept 18.9% of revenue as net income.
DLB profit margins
DLB growth rates
to FY2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +5.9% | +2.5% | +3.0% | +3.3% |
| Gross profit | +4.9% | +2.2% | +3.2% | +3.1% |
| Operating income | +0.1% | +6.8% | +3.7% | +2.2% |
| Net income | −2.6% | +11.5% | +2.0% | +3.5% |
| EPS (diluted) | +11.8% | +10.5% | +7.3% | +6.9% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
DLB quarterly EPS vs estimates
Dolby Laboratories beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: November 17, 2026 (estimate $0.91).
DLB income statement
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.35B | $1.27B | $1.01B | $1.25B | $1.28B | $1.16B | $1.24B | $1.05B | $1.08B | $1.03B |
| Cost of revenue | $160.1M | $140.5M | $117.0M | $141.4M | $130.0M | $146.5M | $160.9M | $127.6M | $118.3M | $109.0M |
| Gross profit | $1.19B | $1.13B | $892.2M | $1.11B | $1.15B | $1.02B | $1.08B | $927.0M | $963.1M | $916.8M |
| Research & development | $261.8M | $263.7M | $201.1M | $261.2M | $253.6M | $239.0M | $237.9M | $236.8M | $233.3M | $219.6M |
| Sales, general & admin | $647.2M | $604.9M | $455.4M | $634.0M | $556.8M | $555.7M | $549.3M | $507.2M | $468.3M | $464.1M |
| Total operating expenses | $924.0M | $868.5M | $656.5M | $895.2M | $810.5M | $794.7M | $787.1M | $744.0M | $701.7M | $683.7M |
| Operating income | $265.0M | $264.7M | $219.2M | $217.2M | $340.8M | $220.6M | $293.6M | $183.1M | $261.5M | $233.0M |
| Interest income | $40.7M | $50.1M | $22.3M | $6.2M | $3.5M | $11.2M | $24.5M | $17.9M | $9.6M | $5.7M |
| Interest expense | — | $34.1M | $161,000 | $394,000 | $479,000 | $186,000 | $170,000 | $198,000 | $127,000 | $125,000 |
| Income before taxes | $303.5M | $312.5M | $241.0M | $215.3M | $354.5M | $239.7M | $282.3M | $196.4M | $256.6M | $235.9M |
| Income taxes | $47.0M | $48.2M | −$49.3M | $31.4M | $36.7M | $8.1M | $26.8M | $154.1M | $54.2M | $49.5M |
| Net income | $255.0M | $261.8M | $191.5M | $184.1M | $310.2M | $231.4M | $255.2M | $41.7M | $201.8M | $185.9M |
| EBITDA | $378.6M | $399.8M | $219.2M | $318.9M | $450.4M | $351.6M | $367.4M | $277.7M | $341.0M | $321.1M |
| EPS (diluted) | $4.25 | $3.80 | $3.57 | $3.15 | $3.68 | $2.99 | $2.97 | $2.93 | $2.60 | $2.43 |
| Gross margin | 88.1% | 89.0% | 88.4% | 88.7% | 89.9% | 87.4% | 87.0% | 87.9% | 89.1% | 89.4% |
| Operating margin | 19.6% | 20.8% | 21.7% | 17.3% | 26.6% | 19.0% | 23.6% | 17.4% | 24.2% | 22.7% |
| Net margin | 18.9% | 20.6% | 19.0% | 14.7% | 24.2% | 19.9% | 20.5% | 4.0% | 18.7% | 18.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $305.0M | $395.6M | $346.7M | $307.0M | $315.5M | $369.6M | $357.0M | $304.8M | $288.8M | $364.5M | $315.6M | $290.6M |
| Cost of revenue | $40.3M | $44.7M | $43.2M | $39.5M | $44.0M | $35.8M | $40.8M | $34.0M | $35.7M | $38.8M | $32.1M | $35.6M |
| Gross profit | $264.7M | $350.9M | $303.5M | $267.5M | $271.5M | $333.7M | $316.2M | $270.8M | $253.2M | $325.7M | $283.5M | $255.0M |
| Research & development | $65.7M | $63.7M | $69.1M | $67.5M | $66.0M | $61.7M | $66.6M | $68.6M | $65.5M | $62.5M | $67.0M | $70.4M |
| Sales, general & admin | $160.7M | $172.1M | $161.8M | $164.2M | $158.5M | $160.0M | $164.5M | $157.1M | $146.8M | $156.8M | $144.2M | $157.5M |
| Total operating expenses | $226.4M | $235.8M | $241.3M | $237.8M | $223.9M | $221.8M | $231.1M | $225.7M | $212.3M | $219.3M | $211.2M | $227.9M |
| Operating income | $38.3M | $115.1M | $62.2M | $29.7M | $47.6M | $112.0M | $85.1M | $45.1M | $40.9M | $106.5M | $72.3M | $27.1M |
| Interest income | — | — | $9.4M | $13.2M | $8.0M | $12.7M | $5.9M | $12.7M | — | $8.6M | — | — |
| Interest expense | $3.5M | $5.0M | $4.1M | — | — | — | — | — | — | — | — | — |
| Income before taxes | $43.8M | $119.7M | $71.6M | $41.7M | $55.5M | $120.2M | $86.1M | $59.7M | $50.2M | $121.7M | $80.8M | $9.0M |
| Income taxes | $14.6M | $24.2M | $17.9M | −$8.0M | $9.0M | $28.0M | $18.0M | $868,000 | $10.5M | $23.5M | $13.3M | −$875,000 |
| Net income | $28.6M | $94.9M | $53.3M | $49.3M | $46.1M | $91.8M | $67.8M | $58.6M | $38.4M | $97.8M | $67.0M | $9.2M |
| EBITDA | $63.3M | $146.5M | $102.5M | $60.4M | $71.5M | $144.7M | $111.2M | $84.1M | $71.4M | $142.5M | $101.8M | $33.3M |
| EPS (diluted) | $0.43 | $1.37 | $1.06 | $0.99 | $0.78 | $1.34 | $1.14 | $0.81 | $0.71 | $1.27 | $1.01 | $0.65 |
| Gross margin | 86.8% | 88.7% | 87.5% | 87.1% | 86.1% | 90.3% | 88.6% | 88.8% | 87.7% | 89.4% | 89.8% | 87.8% |
| Operating margin | 12.5% | 29.1% | 17.9% | 9.7% | 15.1% | 30.3% | 23.8% | 14.8% | 14.1% | 29.2% | 22.9% | 9.3% |
| Net margin | 9.4% | 24.0% | 15.4% | 16.1% | 14.6% | 24.8% | 19.0% | 19.2% | 13.3% | 26.8% | 21.2% | 3.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in DLB's financial statements (latest annual report filed November 18, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
DLB financial results
In fiscal year 2025 (ended September 30, 2025), Dolby Laboratories reported revenue of $1.3 billion, up 5.9% from the year before. It had net income of $255.0 million (down 2.6%), a net profit margin of 18.9%. Diluted earnings per share came to $4.25. Over five years revenue grew at an average rate of 3.0% a year.
See the DLB stock overview for the latest quote and news, or the DLB chart for price history and technical indicators.
DLB income statement FAQ
What is Dolby Laboratories's annual revenue?
Dolby Laboratories reported total revenue of $1.3 billion for fiscal year 2025, which ended on September 30, 2025. That was up 5.9% from $1.3 billion the previous year.
Is Dolby Laboratories profitable?
Yes. Dolby Laboratories reported net income of $255.0 million in fiscal 2025, a net profit margin of 18.9%; its operating margin was 19.6%.
What is Dolby Laboratories's gross margin?
Dolby Laboratories's gross margin was 88.1% in fiscal 2025: for every $100 of revenue, Dolby Laboratories kept $88 after the direct cost of its products and services.
How much does Dolby Laboratories spend on research and development?
Dolby Laboratories spent $261.8 million on research and development in fiscal 2025, 19.4% of revenue.
How fast is Dolby Laboratories growing?
Revenue grew 3.0% a year on average over the last five fiscal years, from $1.2 billion to $1.3 billion.
What are Dolby Laboratories's earnings per share?
Dolby Laboratories earned $4.25 per diluted share in fiscal 2025, compared with $3.80 a year earlier.
When will Dolby Laboratories report its next earnings?
Dolby Laboratories is expected to report results for the quarter ending September 30, 2026 on November 17, 2026 after the market closes.
When does Dolby Laboratories's fiscal year end?
Dolby Laboratories's fiscal year ends in September. The latest annual report covers the year ended September 30, 2025 and was filed on November 18, 2025.